We found each expressed high levels of ROR1, with a mean level comparable to that of CLL cells within the top 25th percentile of ROR1 among 1568 patients examined in our reported cohort (top quartile, n = 392) (Fig. 1A) [24]. Here, ROR1 is linked to B-cell chronic lymphocytic leukemia.